• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, December 9, 2022

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by HealthITAnalytics cited a study pubished in the December 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “On the Impact of Predictive Analytics–Driven Disease Management Interventions,” showed that predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.


An article by Wired referenced a study published in a 2016 supplement to AJMC®, titled “Economic Costs of Hemophilia and the Impact of Prophylactic Treatment on Patient Management.” The study indicated that intravenous infusions for the management of hemophilia cost patients an average of $127,194 per year.

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.